Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: FOSUN PHARMA(02196) the Revenue is 11.34 B (+12.36%), Beat estimate;the EBIT is 1.559 B (+7.15%), Beat estimate;the EPS is 0.374 (+20.46%), Meet estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
11.34B12.36%
11.16B10.63%
+0.17B1.73%
EBITExceed expectations
1.56B7.15%
0.99B31.99%
+0.57B39.14%
EPS
0.374120.46%
0.374120.46%
0.00000.00%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf